Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model

Casey Cook, Sylvia Kang, Yari Carlomagno, Wen Lang Lin, Mei Yue, Aishe Kurti, Mitsuru Shinohara, Karen Jansen-West, Emilie Perkerson, Monica Castanedes-Casey, Linda Rousseau, Virginia Phillips, Guojun D Bu, Dennis W Dickson, Leonard Petrucelli, John D. Fryer

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Aberrant tau protein accumulation drives neurofibrillary tangle (NFT) formation in several neurodegenerative diseases. Currently, efforts to elucidate pathogenic mechanisms and assess the efficacy of therapeutic targets are limited by constraints of existing models of tauopathy. In order to generate amore versatile mousemodel of tauopathy, somatic brain transgenesiswas utilized to deliver adeno-associated virus serotype 1 (AAV1) encoding human mutant P301L-tau comparedwith GFP control. At 6months of age, we observed widespread human tau expression with concomitant accumulation of hyperphosphorylated and abnormally folded proteinase K resistant tau. However, no overt neuronal loss was observed, though significant abnormalities were noted in the postsynaptic scaffolding protein PSD95. Neurofibrillary pathologywas also detected with Gallyas silver stain and Thioflavin-S, and electron microscopy revealed the deposition of closely packed filaments. In addition to classic markers of tauopathy, significant neuroinflammation and extensive gliosis were detected in AAV1-TauP301L mice. This model also recapitulates the behavioral phenotype characteristic ofmousemodels of tauopathy, including abnormalities in exploration, anxiety, and learning andmemory. These findings indicate that biochemical and neuropathological hallmarks of tauopathies are accurately conserved and are independent of cell death in this novel AAV-based model of tauopathy, which offers exceptional versatility and speed in comparison with existing transgenic models. Therefore, we anticipate this approach will facilitate the identification and validation of genetic modifiers of disease, as well as accelerate preclinical assessment of potential therapeutic targets.

Original languageEnglish (US)
Pages (from-to)6198-6212
Number of pages15
JournalHuman Molecular Genetics
Volume24
Issue number21
DOIs
StatePublished - 2015

Fingerprint

Tauopathies
Dependovirus
tau Proteins
Endopeptidase K
Inborn Genetic Diseases
Neurofibrillary Tangles
Gliosis
Silver
Neurodegenerative Diseases
Drive
Electron Microscopy
Cell Death
Coloring Agents
Anxiety
Learning
Phenotype
Brain
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model. / Cook, Casey; Kang, Sylvia; Carlomagno, Yari; Lin, Wen Lang; Yue, Mei; Kurti, Aishe; Shinohara, Mitsuru; Jansen-West, Karen; Perkerson, Emilie; Castanedes-Casey, Monica; Rousseau, Linda; Phillips, Virginia; Bu, Guojun D; Dickson, Dennis W; Petrucelli, Leonard; Fryer, John D.

In: Human Molecular Genetics, Vol. 24, No. 21, 2015, p. 6198-6212.

Research output: Contribution to journalArticle

Cook, C, Kang, S, Carlomagno, Y, Lin, WL, Yue, M, Kurti, A, Shinohara, M, Jansen-West, K, Perkerson, E, Castanedes-Casey, M, Rousseau, L, Phillips, V, Bu, GD, Dickson, DW, Petrucelli, L & Fryer, JD 2015, 'Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model', Human Molecular Genetics, vol. 24, no. 21, pp. 6198-6212. https://doi.org/10.1093/hmg/ddv336
Cook, Casey ; Kang, Sylvia ; Carlomagno, Yari ; Lin, Wen Lang ; Yue, Mei ; Kurti, Aishe ; Shinohara, Mitsuru ; Jansen-West, Karen ; Perkerson, Emilie ; Castanedes-Casey, Monica ; Rousseau, Linda ; Phillips, Virginia ; Bu, Guojun D ; Dickson, Dennis W ; Petrucelli, Leonard ; Fryer, John D. / Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model. In: Human Molecular Genetics. 2015 ; Vol. 24, No. 21. pp. 6198-6212.
@article{513d186d174f4b2ca7e1ba737796db22,
title = "Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model",
abstract = "Aberrant tau protein accumulation drives neurofibrillary tangle (NFT) formation in several neurodegenerative diseases. Currently, efforts to elucidate pathogenic mechanisms and assess the efficacy of therapeutic targets are limited by constraints of existing models of tauopathy. In order to generate amore versatile mousemodel of tauopathy, somatic brain transgenesiswas utilized to deliver adeno-associated virus serotype 1 (AAV1) encoding human mutant P301L-tau comparedwith GFP control. At 6months of age, we observed widespread human tau expression with concomitant accumulation of hyperphosphorylated and abnormally folded proteinase K resistant tau. However, no overt neuronal loss was observed, though significant abnormalities were noted in the postsynaptic scaffolding protein PSD95. Neurofibrillary pathologywas also detected with Gallyas silver stain and Thioflavin-S, and electron microscopy revealed the deposition of closely packed filaments. In addition to classic markers of tauopathy, significant neuroinflammation and extensive gliosis were detected in AAV1-TauP301L mice. This model also recapitulates the behavioral phenotype characteristic ofmousemodels of tauopathy, including abnormalities in exploration, anxiety, and learning andmemory. These findings indicate that biochemical and neuropathological hallmarks of tauopathies are accurately conserved and are independent of cell death in this novel AAV-based model of tauopathy, which offers exceptional versatility and speed in comparison with existing transgenic models. Therefore, we anticipate this approach will facilitate the identification and validation of genetic modifiers of disease, as well as accelerate preclinical assessment of potential therapeutic targets.",
author = "Casey Cook and Sylvia Kang and Yari Carlomagno and Lin, {Wen Lang} and Mei Yue and Aishe Kurti and Mitsuru Shinohara and Karen Jansen-West and Emilie Perkerson and Monica Castanedes-Casey and Linda Rousseau and Virginia Phillips and Bu, {Guojun D} and Dickson, {Dennis W} and Leonard Petrucelli and Fryer, {John D.}",
year = "2015",
doi = "10.1093/hmg/ddv336",
language = "English (US)",
volume = "24",
pages = "6198--6212",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "21",

}

TY - JOUR

T1 - Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model

AU - Cook, Casey

AU - Kang, Sylvia

AU - Carlomagno, Yari

AU - Lin, Wen Lang

AU - Yue, Mei

AU - Kurti, Aishe

AU - Shinohara, Mitsuru

AU - Jansen-West, Karen

AU - Perkerson, Emilie

AU - Castanedes-Casey, Monica

AU - Rousseau, Linda

AU - Phillips, Virginia

AU - Bu, Guojun D

AU - Dickson, Dennis W

AU - Petrucelli, Leonard

AU - Fryer, John D.

PY - 2015

Y1 - 2015

N2 - Aberrant tau protein accumulation drives neurofibrillary tangle (NFT) formation in several neurodegenerative diseases. Currently, efforts to elucidate pathogenic mechanisms and assess the efficacy of therapeutic targets are limited by constraints of existing models of tauopathy. In order to generate amore versatile mousemodel of tauopathy, somatic brain transgenesiswas utilized to deliver adeno-associated virus serotype 1 (AAV1) encoding human mutant P301L-tau comparedwith GFP control. At 6months of age, we observed widespread human tau expression with concomitant accumulation of hyperphosphorylated and abnormally folded proteinase K resistant tau. However, no overt neuronal loss was observed, though significant abnormalities were noted in the postsynaptic scaffolding protein PSD95. Neurofibrillary pathologywas also detected with Gallyas silver stain and Thioflavin-S, and electron microscopy revealed the deposition of closely packed filaments. In addition to classic markers of tauopathy, significant neuroinflammation and extensive gliosis were detected in AAV1-TauP301L mice. This model also recapitulates the behavioral phenotype characteristic ofmousemodels of tauopathy, including abnormalities in exploration, anxiety, and learning andmemory. These findings indicate that biochemical and neuropathological hallmarks of tauopathies are accurately conserved and are independent of cell death in this novel AAV-based model of tauopathy, which offers exceptional versatility and speed in comparison with existing transgenic models. Therefore, we anticipate this approach will facilitate the identification and validation of genetic modifiers of disease, as well as accelerate preclinical assessment of potential therapeutic targets.

AB - Aberrant tau protein accumulation drives neurofibrillary tangle (NFT) formation in several neurodegenerative diseases. Currently, efforts to elucidate pathogenic mechanisms and assess the efficacy of therapeutic targets are limited by constraints of existing models of tauopathy. In order to generate amore versatile mousemodel of tauopathy, somatic brain transgenesiswas utilized to deliver adeno-associated virus serotype 1 (AAV1) encoding human mutant P301L-tau comparedwith GFP control. At 6months of age, we observed widespread human tau expression with concomitant accumulation of hyperphosphorylated and abnormally folded proteinase K resistant tau. However, no overt neuronal loss was observed, though significant abnormalities were noted in the postsynaptic scaffolding protein PSD95. Neurofibrillary pathologywas also detected with Gallyas silver stain and Thioflavin-S, and electron microscopy revealed the deposition of closely packed filaments. In addition to classic markers of tauopathy, significant neuroinflammation and extensive gliosis were detected in AAV1-TauP301L mice. This model also recapitulates the behavioral phenotype characteristic ofmousemodels of tauopathy, including abnormalities in exploration, anxiety, and learning andmemory. These findings indicate that biochemical and neuropathological hallmarks of tauopathies are accurately conserved and are independent of cell death in this novel AAV-based model of tauopathy, which offers exceptional versatility and speed in comparison with existing transgenic models. Therefore, we anticipate this approach will facilitate the identification and validation of genetic modifiers of disease, as well as accelerate preclinical assessment of potential therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=84949187245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949187245&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddv336

DO - 10.1093/hmg/ddv336

M3 - Article

C2 - 26276810

AN - SCOPUS:84949187245

VL - 24

SP - 6198

EP - 6212

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 21

ER -